Jason M. Cox
RG Biopharma (United States)(US)CTI BioPharma (Italy)(IT)
Publications by Year
Research Areas
Synthetic Organic Chemistry Methods, Diabetes Treatment and Management, Carbohydrate Chemistry and Synthesis, Marine Toxins and Detection Methods, Neuropeptides and Animal Physiology
Most-Cited Works
- → A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice(2014)384 cited
- → Small-molecule inhibitors of HIV-1 entry block receptor-induced conformational changes in the viral envelope glycoproteins(2004)255 cited
- → Omarigliptin (MK-3102): A Novel Long-Acting DPP-4 Inhibitor for Once-Weekly Treatment of Type 2 Diabetes(2014)167 cited
- → Localized Changes in the gp120 Envelope Glycoprotein Confer Resistance to Human Immunodeficiency Virus Entry Inhibitors BMS-806 and #155(2004)126 cited
- → C-Glycosides to Fused Polycyclic Ethers. A Formal Synthesis of (±)-Hemibrevetoxin B(2001)103 cited
- → C-Glycosides to fused polycyclic ethers(2002)96 cited
- →